Professional Documents
Culture Documents
Our History: Medical Devices
Our History: Medical Devices
Overview
Our History
Olympus was born in 1919 with the purpose of manufacturing microscopes domestically.
The Company succeeded in developing the world’s first practical gastrocamera roughly 30 years later.
For 100 years from the delivery of its first product, Olympus has continued to create new value for society.
(FY) 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
1919 –1950s 1960 –1980s 1990 – 2010 2011– 2015 2016 – 2018 2019 –
From the Founding of Olympus and Evolution as an Integrated Optical Diversification of Medical Field Unveiled “Back to Basics” Slogan Transition from Stage of Reconstructing Aiming to Become a Truly Global
the Path to Business Modernization Manufacturer and Expansion of and Began Shifting Resources to Management to Stage of Sustainable Medtech Company
Overseas Sales Networks Medical Field Growth and Development
1919 Established as Takachiho Seisakusho to 1964 Established Olympus Europe 2001 Commenced collaboration with Terumo 2011 Deferred recording of past losses discovered 2016 Increased production capacity (completed 2019
Announced corporate transformation plan,
manufacture microscopes in Japan 1968 Established Olympus Corporation of America Corporation 2012 Appointed new management team construction of new buildings) at medical Transform Olympus
1921 Registered trademark as Olympus 1979 Established U.S. location in California (currently 2004 Acquired Celon AG Formed business and capital alliance with endoscope development and production Announced corporate strategy
1949 Name changed to Olympus Optical Co., Ltd. world’s largest endoscope service center) 2008 Established first training center in China Sony Corporation sites(Aizu, Shirakawa, and Aomori)
Company listed on Tokyo Stock Exchange 1989 Established Beijing residential office and (Shanghai) Transferred Information & Communication 2017 Acquired Image Stream Medical, Inc.,
(TSE) corporation in Singapore Acquired Gyrus Group PLC to strengthen Business of the United States
surgical area of medical field 2013 Security on Alert Designation placed on 2018 Introduced new Corporate Philosophy
Please refer to Chapter 02 for
Company stock by TSE removed
details of corporate strategy
Procured capital through public offering in
Evolution of Medical Field overseas markets (approx. ¥110 billion)
Development of
World’s First Practical Gastrocamera Entry into Surgical Device Business New Era of Videoscopes Development of Endoscopic Surgery Advent of Observation Using Specific Light Spectra
Olympus succeeded in creating a gastrocamera Predicting that endoscopes would eventually be The development of videoscopes, which feature Olympus continued to release innovative products, Olympus continued to accelerate the advance of
through joint development between the Company’s used in surgery, Olympus acquired German rigid imaging elements such as CCDs built into their distal including HD surgical endoscopes—the world’s first technologies, such as narrow band imaging (NBI)
R&D team and a physician in the Department of endoscope manufacturer Winter & Ibe GmbH in tips, contributed to a substantial increase in the surgical energy device to integrate both advanced technologies. As a result, endoscopes evolved from
Gastroenterology of The University of Tokyo. The 1979 and expanded its business into the surgical accuracy of diagnoses. This increase in accuracy bipolar and ultrasonic energy—and 3D and 4K being mere observation tools to becoming medical devices
introduction of fiberscopes made it possible to see endoscope field. came from the ability to display images on monitors surgical endoscopes. capable of treatment and therapy.
directly inside a patient’s stomach in real time. for multiple healthcare professionals to view.
1920 1936 1963 1968 1983 2006 2009 2013 2016 2016 2016 2019
Introduced Introduced Olympus’ first Launched the Olympus Launched Company’s Launch of AH2 microscope Introduced OmniScan iX Introduced first Launched flagship Launched IPLEX NX Released FV3000 Introduced VANTA, Launched OLYMPUS
Asahi 600x microscope camera, the Semi-Olympus Pen F, the world’s first first industrial-use series, the world’s first non-destructive testing Olympus mirrorless mirrorless camera industrial videoscope laser scanning handheld X-ray OM-D E-M1X, an OM-D
I, marking entry into half-size SLR camera fiberscope microscope with autofocus instrument camera, OLYMPUS OLYMPUS OM-D confocal microscope fluorescence (XRF) system designed for
camera business functionality PEN E-P1 E-M1 analyzer professionals
Overview
80 %
At a Glance
Overseas Revenue Over
The medical field, which consists of the Endoscopic Solutions Division and the Therapeutic Solutions Division,
accounts for 80% of Olympus’ revenue. Others
¥19.2 billion
Medical Field (2.4%)
The gastrointestinal endoscopes contribute to the early The Therapeutic Solutions Division provides a variety of The Scientific Solutions Division provides microscopes which Olympus The Imaging Division provides Olympus brand cameras, which
diagnosis of diseases while its surgical endoscopes allow for medical device that meets the expectations of healthcare has been manufacturing since its inception. These microscopes boast unparalleled image quality realized through world-leading
minimally invasive treatments for reducing the burden placed professionals and people around the world. Such device are used in various fields, whether for conducting blood tests or lens processing technologies and have won the hearts of
on patient bodies. By providing such device, we support includes endotherapy devices equipped on gastrointestinal pathological examinations related to cancer diagnosis in hospitals and photographers around the world. We continue to introduce the
healthcare professionals and contribute to the health of people endoscopes for treatments and therapies, and energy devices other facilities, assisting advanced research in the life science and world to such unique cameras as our compact, lightweight
around the world. Our global market share of gastrointestinal for use in blood vessel sealing and tissue cutting in endoscopic medical fields, or performing quality control on manufacturing lines. mirrorless cameras and our Tough series of dustproof,
endoscopes, one of our core products, is over 70%. surgery as well as endoscopes for use in urology/gynecology Furthermore, the industrial videoscopes and ultrasonic flaw detectors waterproof cameras that are ideal for outdoor use.
and the ENT field. offered in this division are used in inspections and examinations
underpinning the safety of social infrastructure.
Urology/gynecology products
*1 FY2020
Surgical microscopes Endoscope reprocessor *2 Olympus initiated the process to split off the Imaging business and transfer it to a
special purpose company managed and operated by Japan Industrial Partners
Non-destructive testing instruments X-ray fluorescence (XRF) analyzers Inc. on January 1, 2021.
Others Share of Revenue*1 In Others, we provide filler material for artificial bone and other biomaterials. In addition, this
0.9% segment is responsible for seeking out new businesses and conducting R&D activities in relation
to such businesses. To develop future pillars supporting the Company, we are searching for new
Maintenance / Service System integration ENT products Energy devices, ¥6.8 billion business opportunities and advancing R&D and discovery activities for acquiring technologies.
surgical single-use devices
Overview
Our Products
Olympus provides two kinds of value, through Early Diagnosis, particularly in terms of gastrointestinal
endoscopes, and Minimally Invasive Treatment with emphasis placed on surgical products. Through this,
we hope to contribute to improvements in the quality of life of patients while also helping to address the
worldwide trend of rising healthcare costs.
Example of early diagnosis of lesions with gastrointestinal endoscopes and Examples of laparoscopic
minimally invasive treatment with endotherapy devices surgical equipment
Endotherapy Devices
Forceps Forceps
To grip or To grip or
The light guide fiber runs from
The light guide fiber runs from separate tissue separate tissue
the light source to the distal
the light source to the distal
end to provide illuaminationend to provide illuamination
inside the stomach. inside the stomach. Instrument channel outlet Instrument channel outlet
Image sensor Objective Objective
Image sensor Instruments for collecting Instruments for collecting Surgical Endoscopes
lens lens
Captures color images Captures color images tissue or performing tissue or performing
of the stomach interior procedures enter through procedures
of the stomach interior this enter through this Connecting a scope to a
via objective lens. via objective lens. channel as well as suction.channel as well as suction. surgical endoscopy system
Overview
EVIS X1 ~ 25 % ~ 20 %
More than
70% EMR and ESD*2 products Resection electrodes
(Knife, snare)
Market Scale (Growth Forecasts) Market Scale (Growth Forecasts) Market Scale (Growth Forecasts)
~ 30 % 5 – 10%
20–25%
Cytology brush
Multidebride*4
Market Scale (Growth Forecasts)
Market Scale (Growth Forecasts) Market Scale (Growth Forecasts)
¥260 – ¥290 billion VISERA ELITE II:
Surgical endoscopy system
compatible with infrared and ¥30– 45 billion ¥800 – 900 billion
(CAGR: 2–4%) 3D observation functions (CAGR: 8– 11%) (CAGR: 3– 5%)
Flexible hysteroscope
*3 For laparoscopic surgery and
open surgery
Note: Market share, market scale, and growth forecast information for this page come from the Company’s research. Market share and market scale are as of March 31, 2020. *4 For rhinology surgery
Growth forecasts are projected for the fiscal year ending March 31, 2020 through March 31, 2023.